101 related articles for article (PubMed ID: 3668854)
1. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat.
Mays DC; Nawoot S; Hilliard JB; Pacula CM; Gerber N
J Pharmacol Exp Ther; 1987 Oct; 243(1):227-33. PubMed ID: 3668854
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
Apseloff G; Shepard DR; Chambers MA; Nawoot S; Mays DC; Gerber N
Drug Metab Dispos; 1990; 18(3):298-303. PubMed ID: 1974189
[TBL] [Abstract][Full Text] [Related]
3. Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometry.
Mays DC; Hecht SG; Unger SE; Pacula CM; Climie JM; Sharp DE; Gerber N
Drug Metab Dispos; 1987; 15(3):318-28. PubMed ID: 2886306
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and induction of drug metabolism by psoralens: alterations in duration of sleep induced by hexobarbital and in clearance of caffeine and hexobarbital in mice.
Apseloff G; Hilliard JB; Gerber N; Mays DC
Xenobiotica; 1991 Nov; 21(11):1461-71. PubMed ID: 1763520
[TBL] [Abstract][Full Text] [Related]
5. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.
Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N
J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766
[TBL] [Abstract][Full Text] [Related]
6. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
O'Leary TD; Sansom LN
J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
Huang JD; Hsieh CY
Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin metabolism in mice.
Chow SA; Fischer LJ
Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
[TBL] [Abstract][Full Text] [Related]
9. The effect of estradiol-17 beta treatment on the metabolism and biliary excretion of phenytoin in the isolated perfused rat liver and in vivo.
Vore M; Montgomery C
J Pharmacol Exp Ther; 1980 Oct; 215(1):71-6. PubMed ID: 7452491
[TBL] [Abstract][Full Text] [Related]
10. Biliary excretion of diphenylhydantoin in the rat. Time-course studies.
Inaba T; Umeda T
Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
Buttar HS
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
[TBL] [Abstract][Full Text] [Related]
12. The effect of pregnancy on the biliary excretion of [14C]phenytoin in the rat.
Vore M; Soliven E; Blunden M
J Pharmacol Exp Ther; 1979 Feb; 208(2):257-62. PubMed ID: 762658
[TBL] [Abstract][Full Text] [Related]
13. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-methoxypsoralen (5-MOP) on arylamine N-acetyltransferase activity in the stomach and colon of rats and human stomach and colon tumor cell lines.
Lee YM; Wu TH
In Vivo; 2005; 19(6):1061-9. PubMed ID: 16277023
[TBL] [Abstract][Full Text] [Related]
15. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
Kim PM; Winn LM; Parman T; Wells PG
J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
Billings RE
J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of cytochrome P-450 by the drug methoxsalen.
Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of 5-methoxypsoralen affects the distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
Lee YM; Chen SF; Li YC; Lin SS; Chung JG
In Vivo; 2002; 16(3):201-13. PubMed ID: 12182117
[TBL] [Abstract][Full Text] [Related]
19. Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia.
Vermeulen NP; Danhof M; Setiawan I; Breimer DD
J Pharmacol Exp Ther; 1983 Jul; 226(1):201-5. PubMed ID: 6864540
[TBL] [Abstract][Full Text] [Related]
20. Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients.
Bowdle TA; Neal GD; Levy RH; Heimbach DM
J Pharmacol Exp Ther; 1980 Apr; 213(1):97-9. PubMed ID: 7359372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
